Stay updated on Pediatric LDX Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Pediatric LDX Safety & Efficacy Clinical Trial page.

Latest updates to the Pediatric LDX Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe study record no longer lists the 2008 U.S. NIH grant/contract reference, and the site revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedThe record presents a completed Phase 3 study evaluating lisdexamfetamine against methylphenidate and placebo in children and adolescents with ADHD. It includes the study design, eligibility criteria, locations, and outcome measures.SummaryDifference72%

- Check22 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH updates and a transition from the term “Artificial Intelligence” to “Super Intelligence.” The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site revision indicator in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Pediatric LDX Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric LDX Safety & Efficacy Clinical Trial page.